SG11201805264RA - Infant formula comprising human milk peptides - Google Patents
Infant formula comprising human milk peptidesInfo
- Publication number
- SG11201805264RA SG11201805264RA SG11201805264RA SG11201805264RA SG11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- infant formula
- peptides
- auckland
- december
- Prior art date
Links
- 235000013350 formula milk Nutrition 0.000 title abstract 3
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 3
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 abstract 1
- 108010065875 beta-casomorphins Proteins 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5424—Dairy protein
- A23V2250/54246—Casein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pediatric Medicine (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 29 June 2017 (29.06.2017) WIPOIPCT (10) International Publication Number WO 2017/111618 A1 (51) International Patent Classification: A61K38/18 (2006.01) A23L 33/18 (2016.01) (21) International Application Number: PCT/NZ2016/050203 (22) International Filing Date: (25) Filing Language: (26) Publication Language: 21 December 2016 (21.12.2016) English English (30) Priority Data: 62/270,955 22 December 2015 (22.12.2015) US (71) Applicant: THE A2 MILK COMPANY LIMITED [NZ/NZ]; C/- Simpson Grierson, Level 27, 88 Shortland Street, Auckland (NZ). (72) Inventors: CLARKE, Andrew John; 58 Gladstone Road, Parnell, Auckland, 1052 (NZ). TRIVEDI, Malav Suchin; 2401 Madison Street, Hollywood, Florida 33020 (US). (74) Agent: CATALYST INTELLECTUAL PROPERTY; Level 5,111 Customhouse Quay, Wellington, 6011 (NZ). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) (54) Title: INFANT FORMULA COMPRISING HUMAN MILK PEPTIDES Figure 6 125n 00 i-H o CJ o & Control hBCM7 bBCM7 bBCM9 Morphine (57) : An infant formula composition containing one or more human beta-casomorphin peptides or precursor proteins there of.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562270955P | 2015-12-22 | 2015-12-22 | |
| PCT/NZ2016/050203 WO2017111618A1 (en) | 2015-12-22 | 2016-12-21 | Infant formula comprising human milk peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805264RA true SG11201805264RA (en) | 2018-07-30 |
Family
ID=59090893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805264RA SG11201805264RA (en) | 2015-12-22 | 2016-12-21 | Infant formula comprising human milk peptides |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20190000128A1 (en) |
| EP (1) | EP3393493A4 (en) |
| JP (1) | JP2018537997A (en) |
| KR (1) | KR20180096704A (en) |
| CN (1) | CN108472335A (en) |
| AU (1) | AU2016377254A1 (en) |
| BR (1) | BR112018012922A2 (en) |
| CA (1) | CA3009360A1 (en) |
| CL (1) | CL2018001728A1 (en) |
| IL (1) | IL260201A (en) |
| MX (1) | MX2018007819A (en) |
| PH (1) | PH12018550097A1 (en) |
| RU (1) | RU2018123201A (en) |
| SG (1) | SG11201805264RA (en) |
| TW (1) | TW201722295A (en) |
| WO (1) | WO2017111618A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102471621B1 (en) * | 2016-03-30 | 2022-11-25 | 디 에이2 밀크 컴퍼니 리미티드 | Beta-Casein and Cognitive Function |
| BR102019023798A2 (en) * | 2019-11-12 | 2021-05-25 | José Ferreira Nunes | milk compost of coconut water and goat's milk and use of the compost |
| US20230301316A1 (en) * | 2020-07-01 | 2023-09-28 | Frieslandcampina Nederland B.V. | Process for the preparation of a powdery composition comprising bioactive molecules |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020015A (en) * | 1988-09-22 | 2000-02-01 | Gaull; Gerald E. | Infant formula compositions and nutrition containing genetically engineered human milk proteins |
| WO1993004171A1 (en) * | 1991-08-19 | 1993-03-04 | Symbicom Aktiebolag | Human beta-casein, process for producing it and use thereof |
| AU771754B2 (en) * | 1999-06-29 | 2004-04-01 | New Zealand Milk Institute Limited, The | Prophylactic dietary supplement based on milk |
| CN103315063A (en) * | 2012-03-19 | 2013-09-25 | 基斯有限公司 | Infant formula milk powder capable of preventing diseases |
| WO2015026245A1 (en) * | 2013-08-23 | 2015-02-26 | The A2 Milk Company Limited | Beta-casein a2 and blood glucose levels |
-
2016
- 2016-12-21 CA CA3009360A patent/CA3009360A1/en not_active Abandoned
- 2016-12-21 SG SG11201805264RA patent/SG11201805264RA/en unknown
- 2016-12-21 JP JP2018532791A patent/JP2018537997A/en not_active Withdrawn
- 2016-12-21 AU AU2016377254A patent/AU2016377254A1/en not_active Abandoned
- 2016-12-21 US US16/065,118 patent/US20190000128A1/en not_active Abandoned
- 2016-12-21 KR KR1020187020586A patent/KR20180096704A/en unknown
- 2016-12-21 EP EP16879450.1A patent/EP3393493A4/en not_active Withdrawn
- 2016-12-21 BR BR112018012922A patent/BR112018012922A2/en not_active Application Discontinuation
- 2016-12-21 RU RU2018123201A patent/RU2018123201A/en not_active Application Discontinuation
- 2016-12-21 WO PCT/NZ2016/050203 patent/WO2017111618A1/en active Application Filing
- 2016-12-21 MX MX2018007819A patent/MX2018007819A/en unknown
- 2016-12-21 CN CN201680079280.7A patent/CN108472335A/en active Pending
- 2016-12-22 TW TW105142611A patent/TW201722295A/en unknown
-
2018
- 2018-06-20 PH PH12018550097A patent/PH12018550097A1/en unknown
- 2018-06-21 IL IL260201A patent/IL260201A/en unknown
- 2018-06-22 CL CL2018001728A patent/CL2018001728A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018123201A (en) | 2020-01-23 |
| US20190000128A1 (en) | 2019-01-03 |
| CL2018001728A1 (en) | 2018-09-28 |
| MX2018007819A (en) | 2018-12-17 |
| EP3393493A4 (en) | 2019-06-26 |
| WO2017111618A1 (en) | 2017-06-29 |
| TW201722295A (en) | 2017-07-01 |
| RU2018123201A3 (en) | 2020-03-02 |
| PH12018550097A1 (en) | 2019-02-11 |
| KR20180096704A (en) | 2018-08-29 |
| CA3009360A1 (en) | 2017-06-29 |
| EP3393493A1 (en) | 2018-10-31 |
| CN108472335A (en) | 2018-08-31 |
| IL260201A (en) | 2018-07-31 |
| AU2016377254A1 (en) | 2018-07-12 |
| BR112018012922A2 (en) | 2018-12-11 |
| JP2018537997A (en) | 2018-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201900269XA (en) | Channel sensing for independent links | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| SG11201805072PA (en) | Nicotine powder delivery system | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201807593TA (en) | Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201901995TA (en) | Crystalline and salt forms of ppar agonist compounds | |
| SG11201810965YA (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201805204WA (en) | Nicotine particle capsule | |
| SG11201903193WA (en) | Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate | |
| SG11201907896PA (en) | Optical system for monitoring the movement of people through a passageway | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer | |
| SG11201908091QA (en) | Aqueous anti-pd-l1 antibody formulation | |
| SG11201810934TA (en) | Microparticles comprising a sulphur-containing compound | |
| SG11201806622PA (en) | Egfl6 specific monoclonal antibodies and methods of their use |